Cannabis won’t reverse Alzheimer’s disease—but in carefully selected cases, cannabinoid formulations may help ease symptoms such as agitation, nighttime restlessness, poor appetite, and caregiver stress. In 2025, the safest approach is adjunctive, measurable, and clinician-coordinated: choose COA-verified products, start low/go slow, and prioritize function and safety (falls, confusion, drug interactions).
Where cannabinoids may help (adjunctive)
- Agitation/sundowning: Low balanced CBD:THC or CBD-forward dosing in the evening may reduce pacing and nighttime wakefulness for some patients.
- Appetite & weight maintenance: Modest THC can nudge appetite; balanced options are often gentler in cognitively impaired adults.
- Sleep continuity: Improving sleep can lower next-day irritability and caregiver burden.
For balanced medical overviews of cannabinoids in supportive care, see the NCI/NIH Cannabis PDQ and NIH Alzheimer’s pages (NIA).
Product fit (COA-verified)
- Daytime clarity (avoid intoxication): Restore – CBD Tincture (CBD-forward) for baseline calm and appetite cues.
- Evening wind-down & sleep: Synergy PM – CBD/THC in very low micro-doses to limit confusion and falls.
- GI-gentle carriers: Restore Olive Oil or Synergy PM Olive Oil if taste/smell sensitivity or dysphagia is present.
Always match the bottle’s lot ID to its Certificate of Analysis (potency + metals/solvents/microbes) before dosing.
Dosing & timing (safety-first)
- Start low, go slow: 1–2 mg total cannabinoids 60–90 minutes before bed; wait a full 2 hours before considering changes. Many older adults do well at ≤2.5 mg.
- Track three signals: nighttime awakenings, agitation episodes, and morning alertness; keep the lowest effective dose.
- Caregiver steps: Use a consistent wind-down routine; avoid late caffeine/screen time; ensure safe nighttime lighting to reduce falls.
Safety, interactions & expectations
- Drug interactions: CBD/THC can affect CYP450 metabolism—review with clinicians if the patient takes cholinesterase inhibitors, memantine, anticoagulants, antipsychotics, or sedatives.
- Psychoactive risk: THC can worsen confusion or unsteadiness; favor CBD-forward by day and tiny balanced doses at night, if any THC is used.
- Not a disease-modifying therapy: Cannabinoids may improve comfort, not cognition or progression.
Next step: personalize with your care team
Our dosing specialists coordinate with neurology and primary care to align ratio, timing, and mg with goals (sleep, agitation, appetite)—and teach caregivers how to read COAs and keep a simple symptom log. Book a consultation or explore COA-verified tinctures.
About the Author
Lee Simpson is the founder of King Harvest, producing FECO and tinctures that are third-party tested and designed for measurable, clinician-friendly dosing.

